Lung cancer : translational and emerging therapies / edited by Kishan J. Pandya, Julie R. Brahmer, Manuel Hidalgo.

Format:

Book

Contributor:

Pandya, Kishan J.

Brahmer, Julie R.

Hidalgo, Manuel, MD

Series:

Translational medicine series ; 3.

Translational medicine series ; 3

Language:

English

Subjects (All):

Lungs--Cancer--Chemotherapy.

Lungs.

Lungs--Cancer--Treatment--Technological innovations.

Lungs--Cancer--Molecular aspects.

Lung Neoplasms--drug therapy.

Antineoplastic Agents--therapeutic use.

Medical Subjects:

Lung Neoplasms--drug therapy.

Antineoplastic Agents--therapeutic use.

Physical Description:

viii, 265 pages : illustrations ; 24 cm.

Place of Publication:

New York : Informa Healthcare, [2007]

Summary:

Lung cancer is the leading cause of cancer-related deaths in the United States. Filling a gap in the literature, this resource translates recent laboratory findings into practical applications for the prevention and control of lung cancer. Featuring chapters by seasoned researchers in the field, this reference reviews current advances in imaging, drug development, molecular therapeutics, genetics, immunotherapy, and chemotherapy to stand at the forefront of technologies for patient diagnosis and treatment.

Acquainting specialists with recent progress in the development of new and effective therapies for disease control, this source reviews the scientific principles, trial results, and clinical implications of emerging and translational therapies and prognostic/predictive markers for lung cancer...enables clinicians to select and utilize new therapies to optimize patient outcomes...conveniently synthesizes emerging therapies such as antiangiogensis and EGFR inhibitors, tumor vaccines, monoclonal antibodies, endothelial receptor antagonists, and combination therapies involving already established treatments into one all-inclusive volume...and identifies current and future targets of therapy, trial design, and patient selection.

Contents:

Molecular biology of lung cancer as the basis for targeted therapy / Oliver Gautschi ... [et al.]

Early clinical trial design issues: patient populations, end points, and barriers / Janet E. Dancey

Antiangiogenic therapy for lung cancer: small-molecule inhibitors / Nithya Ramnath and Alex A. Adjei

Antiangiogenic therapy for lung cancer: antibodies and other novel agents / Sarita Dubey and Ravi Salgia

Epidermal growth factor receptor inhibition in non-small cell lung cancer / Antonio Jimeno and Manuel Hidalgo

Epidermal growth factor receptor targeted therapy

markers of sensitivity and response / Rafal Dziadziuszko, Barbara Szostakiewicz, and Fred R. Hirsch

Other novel targeted therapies in lung cancer / Kyriakos P. Papadopoulos and Anthony W. Tolcher

Lung cancer vaccines / Cheryl Ho ... [et al.]

Advances in chemoradiation treatment of locoregionally advanced non-small cell lung cancer / Michael T. Milano and Yuhchyau Chen

Advances in the treatment of brain metastases / Malika L. Siker and Minesh P. Mehta

Recent advances in imaging for lung cancer / Shweta Bhatt, Kristopher M. Skwarski, and Vikram S. Dogra.

Notes:

Includes bibliographical references and index.

ISBN:

0849390214

9780849390210

OCLC:

84900500

Online:

Publisher description